Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.

Ozer, H; Golomb, H M; Zimmerman, H; Spiegel, R J.

J Natl Cancer Inst ; 81(8): 594-602, 1989 Apr 19.

Artículo en Inglés | MEDLINE | ID: mdl-2495367

2.

Role of cytoplasmic lipids in altering diphenylhexatriene fluorescence polarization in malignant cells.

Spiegel, R J; Magrath, I T; Shutta, J A.

Cancer Res ; 41(2): 452-8, 1981 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-7448790

3.

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Sarosy, G A; Brown, T D; Von Hoff, D D; Spiegel, R J; Golando, J P; Beougher, K L; Kuhn, J G; Kisner, D L.

Cancer Res ; 46(10): 5368-71, 1986 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3756887

4.

Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.

Spiegel, R J; Blum, R H; Levin, M; Pinto, C A; Wernz, J C; Speyer, J L; Hoffman, K S; Muggia, F M.

Cancer Res ; 42(1): 354-8, 1982 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-7053862

5.

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

Green, M D; Speyer, J L; Hochster, H S; Liebes, L F; Dunleavy, S; Widman, T; Wernz, J C; Blum, R H; Spiegel, R J; Muggia, F M.

Cancer Res ; 48(9): 2574-8, 1988 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-3356017

6.

A phase I clinical trial of recombinant DNA gamma interferon.

Brown, T D; Koeller, J; Beougher, K; Golando, J; Bonnem, E M; Spiegel, R J; Von Hoff, D D.

J Clin Oncol ; 5(5): 790-8, 1987 May.

Artículo en Inglés | MEDLINE | ID: mdl-3106584

7.

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

Costanzi, J J; Cooper, M R; Scarffe, J H; Ozer, H; Grubbs, S S; Ferraresi, R W; Pollard, R B; Spiegel, R J.

J Clin Oncol ; 3(5): 654-9, 1985 May.

Artículo en Inglés | MEDLINE | ID: mdl-3998782

8.

Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas.

Tsokos, G C; Balow, J E; Spiegel, R J; Magrath, I T.

Medicine (Baltimore) ; 60(3): 218-29, 1981 May.

Artículo en Inglés | MEDLINE | ID: mdl-6894477

9.

Intron A (interferon alfa-2b): clinical overview and future directions.

Spiegel, R J.

Semin Oncol ; 13(3 Suppl 2): 89-101, 1986 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-3532338

10.

The alpha interferons: clinical overview.

Spiegel, R J.

Semin Oncol ; 14(2 Suppl 2): 1-12, 1987 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-3296210

11.

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A).

Spiegel, R J; Spicehandler, J R; Jacobs, S L; Oden, E M.

Am J Med ; 80(2): 223-8, 1986 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-3484902

12.

Plasma lipid alterations in leukemia and lymphoma.

Spiegel, R J; Schaefer, E J; Magrath, I T; Edwards, B K.

Am J Med ; 72(5): 775-82, 1982 May.

Artículo en Inglés | MEDLINE | ID: mdl-7081275

13.

A three-dimensional finite-difference thermoregulatory model of a squirrel monkey.

Spiegel, R J; Fatmi, M B.

Int J Radiat Oncol Biol Phys ; 12(6): 983-92, 1986 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-3721940

14.

Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies.

Spiegel, R J; Schaefer, E J; Magrath, I T; Edwards, B K.

Leuk Res ; 7(5): 647-54, 1983.

Artículo en Inglés | MEDLINE | ID: mdl-6645602

15.

Treatment of metastatic malignant melanoma with recombinant interferon alpha 2.

Robinson, W A; Mughal, T I; Thomas, M R; Johnson, M; Spiegel, R J.

Immunobiology ; 172(3-5): 275-82, 1986 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-3804370

16.

Alpha interferons: a clinical overview.

Spiegel, R J.

Urology ; 34(4 Suppl): 75-9; discussion 87-96, 1989 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-2678686

17.

Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.

Oken, M M; Kyle, R A; Greipp, P R; Kay, N E; Tsiatis, A; Gregory, S A; Spiegel R, J; O'Connell M, J.

Leuk Lymphoma ; 20(5-6): 447-52, 1996 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-8833401

18.

Acne arthralgia.

Lane JMLeyden, J J; Spiegel, R J.

J Bone Joint Surg Am ; 58(5): 673-5, 1976 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-132449

19.

Comparison of finite-difference time-domain SAR calculations with measurements in a heterogeneous model of man.

Spiegel, R J; Fatmi, M B; Stuchly, S S; Stuchly, M A.

IEEE Trans Biomed Eng ; 36(8): 849-55, 1989 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-2759643

20.

Technical assessment of fuel cell operation on anaerobic digester gas at the Yonkers, NY, wastewater treatment plant.

Spiegel, R J; Preston, J L.

Waste Manag ; 23(8): 709-17, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-14522189

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.

Role of cytoplasmic lipids in altering diphenylhexatriene fluorescence polarization in malignant cells.

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

A phase I clinical trial of recombinant DNA gamma interferon.

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas.

Intron A (interferon alfa-2b): clinical overview and future directions.

The alpha interferons: clinical overview.

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A).

Plasma lipid alterations in leukemia and lymphoma.

A three-dimensional finite-difference thermoregulatory model of a squirrel monkey.

Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies.

Treatment of metastatic malignant melanoma with recombinant interferon alpha 2.

Alpha interferons: a clinical overview.

Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.

Acne arthralgia.

Comparison of finite-difference time-domain SAR calculations with measurements in a heterogeneous model of man.

Technical assessment of fuel cell operation on anaerobic digester gas at the Yonkers, NY, wastewater treatment plant.